Intracystic glucose’s diagnostic accuracy and other advantages should make it the preferred fluid biomarker to identify pancreatic cysts with malignant potential, Cleveland Clinic researchers contend.
Uncovering the Natural History of Pancreatic Cysts
A study of one of the largest pancreatic cyst databases yields several insights into which cysts may carry malignant potential.
Intracystic Glucose Levels Offer Good Accuracy for Differentiating Precancerous Mucinous from Benign Nonmucinous Pancreatic Cysts
Cleveland Clinic researchers present study at DDW 2018 which found that measuring intracystic glucose levels was more accurate than current testing protocols for distinguishing between precancel mucinous cysts and benign nonmutinous cysts.